Search

Additional file 4: Table S3. Meta-regression showing the possible source of heterogeneity of meta-analysis.

Additional file 1: Table S1. PRISMA 2009 Checklist.

Additional file 5: Fig. S10. Sensitivity analyses: a) survival rate, b) pulmonary fibrosis scores.

Additional file 2: Table S2. The detailed search strategy.

Additional file 6: Fig. S11. Funnel plots for (a) survival rate, (b) pulmonary fibrosis scores.

Additional file 3: Figure S1. Forest plot summarizing the relationship between PF models and pulmonary fibrosis scores in preclinical models of PF. Figure S2. Forest plot summarizing the relationship between MSC type and pulmonary fibrosis scores in preclinical models of PF. Figure S3. Forest plot summarizing the relationship between MSC dose and pulmonary fibrosis scores in preclinical models of PF. Figure S4. Forest plot summarizing the relationship between MSC route and pulmonary fibrosis scores in preclinical models of PF. Figure S5. Forest plot summarizing the relationship between transplant type and pulmonary fibrosis scores in preclinical models of PF. Figure S6. Forest plot summarizing the relationship between timing of MSC therapy after PF and pulmonary fibrosis scores in preclinical models of PF. Figure S7. Forest plot summarizing the relationship between geographic location and pulmonary fibrosis scores in preclinical models of PF. Figure S8. Forest plot summarizing the relationship between BMSC dose and pulmonary fibrosis scores in preclinical models of PF. Figure S9. Forest plot summarizing the relationship between ADMSC dose and pulmonary fibrosis scores in preclinical models of PF.